Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Resectable Lung Non-Small Cell Carcinoma × nedaplatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Squamous Cell Carcinoma of Head and Neck 1 Resectable Lung Non-Small Cell Carcinoma 1 Nasopharyngeal Carcinoma 1 Immunotherapy Esophagus Cancer 1 Hepatic Artery Infusion 1 Advanced Solid Tumor 1

Interventions

nedaplatin 1 X-Rays 1 Specimen Handling 1 Protons 1 Proton Therapy 1 Platinum Compounds 1 Pemetrexed 1 Paclitaxel 1 Docetaxel 1 Cisplatin 1 Carboplatin 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06775275 2025-01-15

A Study of Adebrelimab in Combination with Chemo with or Without Bevacizumab Neoadjuvant Therapy for Resectable NSCLC

The First Affiliated Hospital of Guangzhou Medical University

Phase 2 Recruiting

Resectable Lung Non-Small Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡